FDA limits Johnson & Johnson's COVID vaccine to some people due to blood clot risk | MPR News

Retrieved on: 2022-05-06 10:48:48

Tags for this article:

Clinical trials

Health

Vaccines

Janssen Pharmaceutica

COVID-19 vaccination in the United States

RNA vaccines

Adenoviridae

Janssen COVID-19 vaccine

Embolic and thrombotic events after COVID-19 vaccination

COVID-19 vaccine

Vaccine

COVID-19 vaccine clinical research

Johnson and Johnson

Click the tags to see associated articles and topics

FDA limits Johnson & Johnson's COVID vaccine to some people due to blood clot risk | MPR News. View article details on HISWAI: https://www.mprnews.org/story/2022/05/05/npr-johnson-and-johnson-covid-vaccine-limited-fda

Excerpt

The chances of dying following after receiving the Janssen vaccine is about 1:2000000. But with multiple COVID-19 vaccines available, ...

Article found on: www.mprnews.org

View Original Article